Cargando…

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer

BACKGROUND: Alternative splicing (AS) is one of the critical post-transcriptional regulatory mechanisms of various cancers and also plays a crucial role in the development of cancers, including endometrial cancer (EC). METHODS: The splicing data and gene expression profiles of EC were obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peigen, He, Junxian, Ye, Huixia, Jiang, Senwei, Li, Yunhui, Li, Xiaomao, Wan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272712/
https://www.ncbi.nlm.nih.gov/pubmed/32547595
http://dx.doi.org/10.3389/fgene.2020.00456
_version_ 1783542314564583424
author Chen, Peigen
He, Junxian
Ye, Huixia
Jiang, Senwei
Li, Yunhui
Li, Xiaomao
Wan, Jing
author_facet Chen, Peigen
He, Junxian
Ye, Huixia
Jiang, Senwei
Li, Yunhui
Li, Xiaomao
Wan, Jing
author_sort Chen, Peigen
collection PubMed
description BACKGROUND: Alternative splicing (AS) is one of the critical post-transcriptional regulatory mechanisms of various cancers and also plays a crucial role in the development of cancers, including endometrial cancer (EC). METHODS: The splicing data and gene expression profiles of EC were obtained from The Cancer Genome Atlas. The corresponding clinical data were extracted from TCGA-CDR. With univariate Cox regression analysis, least absolute shrinkage and selection operator model, and multivariate Cox regression analysis, the survival-related AS events were selected. Functional enrichment analysis was also performed to investigate the functions of these AS events. Splicing factors and AS regulation network were constructed to understand the correlation among these AS events. RESULT: A total of 1826 AS events were identified as survival-related events. Functional enrichment analysis showed that these AS events were associated with several immune system-related processes. Then, the prognostic signatures were developed based on these survival-related events and acted as an independent prognostic factor for EC. Splicing factors and AS regulation network were also constructed to understand the regulatory mechanisms of AS events in EC. CONCLUSION: This study systematically analyzed the role of AS events in EC and developed the prognostic model for EC.
format Online
Article
Text
id pubmed-7272712
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72727122020-06-15 Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer Chen, Peigen He, Junxian Ye, Huixia Jiang, Senwei Li, Yunhui Li, Xiaomao Wan, Jing Front Genet Genetics BACKGROUND: Alternative splicing (AS) is one of the critical post-transcriptional regulatory mechanisms of various cancers and also plays a crucial role in the development of cancers, including endometrial cancer (EC). METHODS: The splicing data and gene expression profiles of EC were obtained from The Cancer Genome Atlas. The corresponding clinical data were extracted from TCGA-CDR. With univariate Cox regression analysis, least absolute shrinkage and selection operator model, and multivariate Cox regression analysis, the survival-related AS events were selected. Functional enrichment analysis was also performed to investigate the functions of these AS events. Splicing factors and AS regulation network were constructed to understand the correlation among these AS events. RESULT: A total of 1826 AS events were identified as survival-related events. Functional enrichment analysis showed that these AS events were associated with several immune system-related processes. Then, the prognostic signatures were developed based on these survival-related events and acted as an independent prognostic factor for EC. Splicing factors and AS regulation network were also constructed to understand the regulatory mechanisms of AS events in EC. CONCLUSION: This study systematically analyzed the role of AS events in EC and developed the prognostic model for EC. Frontiers Media S.A. 2020-05-29 /pmc/articles/PMC7272712/ /pubmed/32547595 http://dx.doi.org/10.3389/fgene.2020.00456 Text en Copyright © 2020 Chen, He, Ye, Jiang, Li, Li and Wan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Chen, Peigen
He, Junxian
Ye, Huixia
Jiang, Senwei
Li, Yunhui
Li, Xiaomao
Wan, Jing
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title_full Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title_fullStr Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title_full_unstemmed Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title_short Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
title_sort comprehensive analysis of prognostic alternative splicing signatures in endometrial cancer
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272712/
https://www.ncbi.nlm.nih.gov/pubmed/32547595
http://dx.doi.org/10.3389/fgene.2020.00456
work_keys_str_mv AT chenpeigen comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT hejunxian comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT yehuixia comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT jiangsenwei comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT liyunhui comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT lixiaomao comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer
AT wanjing comprehensiveanalysisofprognosticalternativesplicingsignaturesinendometrialcancer